organophosphonates has been researched along with Carotid Artery Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhtar, S; Benter, IF; Canatan, H; Yousif, MH | 1 |
| Abou-Gharbia, M; Baudy, RB; Bramlett, DR; Fletcher, H; Katz, AH; Kowal, DM; Moyer, JA; Tasse, RP; Yardley, JP; Zaleska, MM | 1 |
2 other study(ies) available for organophosphonates and Carotid Artery Diseases
| Article | Year |
|---|---|
Inhibition of Ca2+/calmodulin-dependent protein kinase II, RAS-GTPase and 20-hydroxyeicosatetraenoic acid attenuates the development of diabetes-induced vascular dysfunction in the rat carotid artery.
Topics: Amidines; Animals; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carotid Arteries; Carotid Artery Diseases; Diabetes Mellitus, Experimental; Hydroxyeicosatetraenoic Acids; Monomeric GTP-Binding Proteins; Organophosphonates; Protein Kinase Inhibitors; Rats; Rats, Wistar; Streptozocin; Sulfonamides; Triazoles; Vascular Diseases; Vasoconstriction; Vasodilation | 2005 |
Design, synthesis, SAR, and biological evaluation of highly potent benzimidazole-spaced phosphono-alpha-amino acid competitive NMDA antagonists of the AP-6 type.
Topics: Animals; Arterial Occlusive Diseases; Benzimidazoles; Binding, Competitive; Brain; Carotid Artery Diseases; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; In Vitro Techniques; Infarction, Middle Cerebral Artery; Male; Mice; Models, Molecular; Neuroprotective Agents; Organophosphonates; Propionates; Radioligand Assay; Rats; Rats, Inbred F344; Receptors, N-Methyl-D-Aspartate; Stereoisomerism | 2001 |